Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
11 2023
Historique:
received: 11 01 2023
accepted: 14 07 2023
medline: 23 10 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

Recent advances in understanding the biology of ankylosing spondylitis (AS) using innovative genomic and proteomic approaches offer the opportunity to address current challenges in AS diagnosis and management. Altered expression of genes, microRNAs (miRNAs) or proteins may contribute to immune dysregulation and may play a significant role in the onset and persistence of inflammation in AS. The ability of exosomes to transport miRNAs across cells and alter the phenotype of recipient cells has implicated exosomes in perpetuating inflammation in AS. This study reports the first proteomic and miRNA profiling of plasma-derived exosomes in AS using comprehensive computational biology analysis. Plasma samples from patients with AS and healthy controls (HC) were isolated via ultracentrifugation and subjected to extracellular vesicle flow cytometry analysis to characterise exosome surface markers by a multiplex immunocapture assay. Cytokine profiling of plasma-derived exosomes and cell culture supernatants was performed. Next-generation sequencing was used to identify miRNA populations in exosomes enriched from plasma fractions. CD4+ T cells were sorted, and the frequency and proliferation of CD4+ T-cell subsets were analysed after treatment with AS-exosomes using flow cytometry. The expression of exosome marker proteins CD63 and CD81 was elevated in the patients with AS compared with HC (q<0.05). Cytokine profiling in plasma-derived AS-exosomes demonstrated downregulation of interleukin (IL)-8 and IL-10 (q<0.05). AS-exosomes cocultured with HC CD4+ T cells induced significant upregulation of IFNα2 and IL-33 (q<0.05). Exosomes from patients with AS inhibited the proliferation of regulatory T cells (Treg), suggesting a mechanism for chronically activated T cells in this disease. Culture of CD4+ T cells from healthy individuals in the presence of AS-exosomes reduced the proliferation of FOXP3+ Treg cells and decreased the frequency of FOXP3+IRF4+ Treg cells. miRNA sequencing identified 24 differentially expressed miRNAs found in circulating exosomes of patients with AS compared with HC; 22 of which were upregulated and 2 were downregulated. Individuals with AS have different immunological and genetic profiles, as determined by evaluating the exosomes of these patients. The inhibitory effect of exosomes on Treg in AS suggests a mechanism contributing to chronically activated T cells in this disease.

Identifiants

pubmed: 37532285
pii: ard-2022-223791
doi: 10.1136/ard-2022-223791
doi:

Substances chimiques

MicroRNAs 0
Forkhead Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1429-1443

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Fataneh Tavasolian (F)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Starlee Lively (S)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Osteoarthritis Research Program, Division of Orthopaedics, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.

Chiara Pastrello (C)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Osteoarthritis Research Program, Division of Orthopaedics, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.
Krembil Research Institute, - Data Science Discovery Centre for Chronic Diseases, University Health Network, Toronto, Ontario, Canada.

Michael Tang (M)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Melissa Lim (M)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Addison Pacheco (A)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Zoya Qaiyum (Z)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Enoch Yau (E)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

Zeynep Baskurt (Z)

Department of Biostatistics, Princess Margaret Cancer Center, 610 University Ave, Toronto, Ontario, Canada.

Igor Jurisica (I)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Osteoarthritis Research Program, Division of Orthopaedics, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.
Krembil Research Institute, - Data Science Discovery Centre for Chronic Diseases, University Health Network, Toronto, Ontario, Canada.
Departments of Medical Biophysics and Computer Science, and Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.

Mohit Kapoor (M)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Osteoarthritis Research Program, Division of Orthopaedics, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.
Department of Surgery, Division of Orthopaedic Surgery and Department of Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Robert D Inman (RD)

Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada robert.inman@uhn.ca.
Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Immunology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Spondylitis Program, Division of Rheumatology, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH